The last couple of weeks of 2021 were dominated by the cross-border nature of the COVID-19 crisis, and the fight against it. While the Netherlands went into the holiday season under a lockdown, complete closures were largely absent in Germany and...
Greece emerged as the EU’s poster child in the fight against Covid-19 during the first few months of the pandemic. Its approach, while effective, is not beyond reproach. We analyse two such contested areas of Covid-19 regulation: permits of movement obtained through SMS, and restrictions to the...
With the circulation of the Coronavirus, governments are trying to restrict the movement of people. Staying at home and limiting unnecessary travel and visits is a frequently used and successful recipe against the flare-ups of...
The European Union (EU) budget is about one percent of the Gross Domestic Product (GDP) of all Member States amounting to about €240 per annum, per citizen. The EU budget redistributes more than €150 billion annually. These funds are directed towards agriculture and regional policy, which operate to...
The ongoing COVID-19 pandemic is arguably one of the biggest crises of modern times. The conflict between the search for a vaccine, and the artificial scarcity created by patent law, has created a catch-22 situation. How will patent law apply to a vaccine under these circumstances?
During the European Council this week all eyes are, again, on the negotiations for the future European Union (EU) budget. Analysts tended to focus mainly on two things. First, the evolution of the sums of money that will be agreed on for the future European Recovery Plan & next Multi-Annual...
In the aftermath of the surge in COVID-19 related government support to businesses and just days after UK Brexit negotiators announced not to extend the deadline for the ongoing negotiations with the European Union, the European Commission launched its “White Paper on levelling the playing field as...
Several pharmaceutical companies all around the world, including in the European Union (EU), have been racing to find a treatment for the virus. Since these may be subject to patent rights, government intervention may be needed.
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
It feels sometimes as if the whole world of science is working exclusively on finding a cure for COVID-19. If you are looking at the search for an effective vaccine, it was recently published in The New York Times that more than 130 vaccine candidates are currently in the pipeline, which is still...
